期刊文献+

118例高胆固醇血症患者调脂治疗达标情况分析

Analysis of reaching cholesterol goal level of 118 hypercholesterolemia cases with drug therapy
下载PDF
导出
摘要 目的 调查高胆固醇血症患者药物治疗达标率。方法 对现行调脂治疗持续时间≥ 2个月的 118例高胆固醇血症患者进行血脂检查 ,并根据 1997年我国制定的《血脂异常防治建议》确定血脂是否达标。结果 总胆固醇 (TC)和低密度脂蛋白胆固醇 (LDL C)总达标率分别为 2 3 7%、38 1% ,他汀类药物LDL C总达标率高于海鱼油和绞股兰 ,每日 2 0mg辛伐他汀LDL C达标率高于每日 2 0mg氟伐他汀。结论 现行调脂治疗达标率较低 ,可能与选择药物的种类和药物剂量有关。 Objective To investigate the rate of reaching goal level in patients with hypercholesterolemia. Methods 118 patients with hypercholesterolemia who had been treated with regulating lipid drugs for at last two months received serum lipid determination. The rate of reaching goal level of cholesterol was judged according to the standard recommended by our country in 1997. Results 23.7% of the patients achieved total cholesterol(TC)goal level and 38.1% of the patients reached low-density lipoprotein cholesterol (LDL-C) goal level. Statins had a higher rate of reaching LDL-C goal level than sea fish oil and jiaogulan (41.9% vs 14.3%, P<0 05 ). 66.7% of the patients treated with simvastatin 20 mg every day achieved LDL-C goal level, while only 24 1% of the patients treated with fluvastatin 20 mg every day did. Conclusions The rate of reaching cholesterol goal level is still low in patients with present treatment. This state can be correlated with variety and dose of chosen drugs.
出处 《岭南心血管病杂志》 2001年第1期24-25,共2页 South China Journal of Cardiovascular Diseases
关键词 高胆固醇血症 药物治疗 目标水平 Hypercholesterolemia Drug therapy Goal level Rate
  • 相关文献

参考文献4

  • 1Larosa JC, Hunninghake D, Bush D, et al. The cholesterol facts. A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. Circulation, 1990, 81: 1721~1733
  • 2方圻,王钟林,宁田海,邵耕,陈在嘉,陆宗良,李健斋,林传骧,周北凡,诸骏仁,诸永康,陶萍,陶寿淇,龚兰生,顾复生,游凯,戴玉华.血脂异常防治建议[J].中华心血管病杂志,1997,25(3):169-175. 被引量:3067
  • 3Cleeman JI, Lenfant C. The National Cholesterol Education Program: Progress and Prospects. J Am Med Assoc, 1998, 280: 2099~104
  • 4Hunninghake D, Bakker-Arkema PG, Wigand JP, et al. Treating to meet NCEP-recommended LDL cholesterol concentrations with atorvastatin, fluvastatin, lovastatin, or simvastatin in patients with risk factors for coronary heart disease. J Famaly Practice, 1998, 47(5): 349~356

共引文献3066

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部